A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

NCT05083182 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Juvenile

Interventions

DRUG: Ustekinumab
DRUG: Guselkumab

Sponsor

Janssen Research & Development, LLC